The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target TIM-1 to limit Zika virus infection

Qi Zhang1, Zhen-Wu Ma1, Hui-Fang Li1

  • 1Department of Infectious Diseases, Zhongnan Hospital of Wuhan University; Hubei Provincial Research Center for Basic Biological Sciences; Medical Research Institute; Frontier Science Center for Immunology and Metabolism; Taikang Center for Life and Medical Sciences; Wuhan University, Wuhan, 430071, China.

PubMed

Insights

MARCH2 and MARCH3 E3 ubiquitin ligases regulate TIM-1, a Zika virus entry receptor. These ligases degrade TIM-1, limiting Zika virus (ZIKV) infection and pathogenesis.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • T-cell immunoglobulin mucin family member-1 (TIM-1) serves as an entry receptor for Zika virus (ZIKV).
  • The regulation of TIM-1's role in ZIKV infection is not fully understood.
  • Post-translational modifications of TIM-1 are critical for its function.

Purpose of the Study:

  • To investigate the post-translational regulation of TIM-1.
  • To identify host factors that control TIM-1 levels and ZIKV entry.
  • To elucidate the role of E3 ubiquitin ligases in regulating TIM-1 and ZIKV infection.

Main Methods:

  • Utilized knockout models for MARCH2 and MARCH3 E3 ubiquitin ligases.
  • Performed co-immunoprecipitation to assess protein interactions.
  • Analyzed TIM-1 ubiquitination and proteasomal degradation pathways.
  • Quantified ZIKV infectivity in cell culture and mouse models.

Main Results:

  • Identified MARCH2 and MARCH3 as negative regulators of TIM-1.
  • MARCH2 and MARCH3 mediate K48-linked polyubiquitination and proteasomal degradation of TIM-1.
  • MARCH2/3 deficiency leads to increased TIM-1 levels and enhanced ZIKV infectivity.
  • MARCH2/3 knockout exacerbates ZIKV pathogenesis in mice.

Conclusions:

  • MARCH2 and MARCH3 act as redundant host restriction factors limiting ZIKV infection.
  • Targeting TIM-1 for degradation by MARCH2/3 is a key mechanism for controlling ZIKV.
  • Understanding TIM-1 regulation by MARCH ligases offers potential therapeutic targets for ZIKV.